Cargando…

Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USA

OBJECTIVE: Ferumoxytol has demonstrated superior efficacy compared with oral iron in treating iron deficiency anemia in chronic kidney disease (CKD) patients. However, an economic evaluation of ferumoxytol has not been conducted. The aim of this study was to analyze the cost-effectiveness of treatin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dahl, Naomi V, Kaper, Robert F, Strauss, William E, Corvino, Frank A, Zivkovic, Marko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5614742/ https://www.ncbi.nlm.nih.gov/pubmed/29033594 http://dx.doi.org/10.2147/CEOR.S139950

Ejemplares similares

Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia: A randomized trial
por: Adkinson, N. Franklin, et al.
Publicado: (2018)

Efficacy and safety of IV ferumoxytol for iron deficiency anemia in patients with cancer
por: Vadhan-Raj, Saroj, et al.
Publicado: (2017)

Ferumoxytol for the treatment of iron deficiency and iron-deficiency anemia of pregnancy
por: Gerb, Jesse, et al.
Publicado: (2021)

Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial
por: Macdougall, Iain C., et al.
Publicado: (2019)

Ferumoxytol versus placebo in iron deficiency anemia: efficacy, safety, and quality of life in patients with gastrointestinal disorders
por: Ford, David C, et al.
Publicado: (2016)

The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2017)

Correction to: The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale
por: Macdougall, Iain C., et al.
Publicado: (2018)

Ferumoxytol versus iron sucrose treatment: a post-hoc analysis of randomized controlled trials in patients with varying renal function and iron deficiency anemia
por: Strauss, William E., et al.
Publicado: (2016)

Comparative safety of intravenous Ferumoxytol versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia: rationale and study design of a randomized double-blind study with a focus on acute hypersensitivity reactions
por: Adkinson, N Franklin, et al.
Publicado: (2017)

Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron
por: Vadhan-Raj, Saroj, et al.
Publicado: (2014)

Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study
por: Vadhan-Raj, Saroj, et al.
Publicado: (2016)

Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review
por: Glaspy, John A, et al.
Publicado: (2020)

A Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy
por: Hetzel, David, et al.
Publicado: (2014)

Safety of intravenous iron isomaltoside for iron deficiency and iron deficiency anemia in pregnancy
por: Wesström, Jan
Publicado: (2020)

Health-related quality of life in patients with iron deficiency anemia: impact of treatment with intravenous iron
por: Strauss, William E, et al.
Publicado: (2018)

Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
por: Froessler, Bernd, et al.
Publicado: (2018)

Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia
por: Friedrisch, João Ricardo, et al.
Publicado: (2015)

Intravenous ferric derisomaltose for the treatment of iron deficiency anemia
por: Auerbach, Michael, et al.
Publicado: (2021)

Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations
por: Koch, Todd A., et al.
Publicado: (2015)

Ferumoxytol: a silver lining in the treatment of anemia of chronic kidney disease or another dark cloud?
por: Pai, Amy Barton, et al.
Publicado: (2012)

Anaphylaxis with elevated serum tryptase after administration of intravenous ferumoxytol
por: Santosh, Sadashiv, et al.
Publicado: (2010)

Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anemia
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2011)

Oral versus intravenous iron therapy in iron deficiency anemia: An observational study
por: Das, Samarendra N., et al.
Publicado: (2020)

Prevalence of Iron Deficiency Anemia Indicated for Intravenous Iron Treatment in the Korean Population
por: Choi, Rihwa, et al.
Publicado: (2023)

Intravenous Iron Technique Evaluation in Chronic Heart Failure With Iron Deficiency Anemia
por: Gosavi, Rohit, et al.
Publicado: (2023)

A systemic review and meta-analysis on the efficacy and safety of ferumoxytol for anemia in chronic kidney disease patients
por: Zuo, Qianwei, et al.
Publicado: (2022)

The Impact of Intravenous Iron on Renal Injury and Function Markers in Patients With Chronic Kidney Disease and Iron Deficiency Without Anemia
por: Kassianides, Xenophon, et al.
Publicado: (2021)

Anemia and iron deficiency in COPD patients: prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron
por: Silverberg, Donald S, et al.
Publicado: (2014)

Relative Incidence of Acute Adverse Events with Ferumoxytol Compared to Other Intravenous Iron Compounds: A Matched Cohort Study
por: Wetmore, James B., et al.
Publicado: (2017)

Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia: Letter to Editor
por: Kanshaiym, Sakiyeva, et al.
Publicado: (2020)

Heme iron polypeptide for the treatment of iron deficiency anemia in non-dialysis chronic kidney disease patients: a randomized controlled trial
por: Nagaraju, Shankar P, et al.
Publicado: (2013)

The effectiveness of intravenous iron for iron deficiency anemia in gastrointestinal cancer patients: a retrospective study
por: Verhaeghe, Laurens, et al.
Publicado: (2017)

Effects of intravenous iron monotherapy for patients with iron deficient anemia undergoing total knee arthroplasty
por: Shin, Kyun-Ho, et al.
Publicado: (2020)

Comparative analysis of oral and intravenous iron therapy in rat models of inflammatory anemia and iron deficiency
por: de Souza, Lara Valente, et al.
Publicado: (2022)

Financial burden associated with discordance to intravenous iron therapies in US patients with iron deficiency anemia
por: Polson, Michael K, et al.
Publicado: (2023)

Safety, pharmacokinetics, and pharmacodynamics of intravenous ferric carboxymaltose in children with iron deficiency anemia
por: Korczowski, Bartosz, et al.
Publicado: (2023)

Iron deficiency and iron deficiency anemia in pregnancy
por: Malinowski, A. Kinga, et al.
Publicado: (2021)

Cost effectiveness of routine duodenal biopsies in iron deficiency anemia
por: Broide, Efrat, et al.
Publicado: (2016)

Intravenous Iron Repletion Does Not Significantly Decrease Platelet Counts in CKD Patients with Iron Deficiency Anemia
por: Dossabhoy, Neville R., et al.
Publicado: (2013)

Intravenous iron alone resolves anemia in patients with functional iron deficiency and lymphoid malignancies undergoing chemotherapy
por: Hedenus, Michael, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_25u057ncrovvt35dqgljgo0031